Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart	Infections, RNA Virus Infections, avian influenza, bird disease, influenza, non-human animal disease, viral infectious disease	Active, not recruiting	Phase 4	2026-01-16		NCT07275060

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Center for Vaccinology	6
Canadian Immunization Research Network	6
CHU de Quebec-Universite Laval	54
Dalhousie University	49
IWK Health Centre	30
McGill University Health Centre/Research Institute of the McGill University Health Centre	139
Public Health Agency of Canada (PHAC)	11
Vaccine Evaluation Center, Canada	3

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Canadian Center for Vaccinology	Halifax	Canada	4
CHU de Québec	Québec	Canada	1
Vaccine Evaluation Center	Vancouver	Canada	2
Vaccine Study Centre of the McGill University Health Centre	Pierrefonds	Canada	1